EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population

Jorge Hernández-Bello, Ana C Lorenzo-Leal, José F Muñoz-Valle iD, José J Morales-Núñez, Saul A Díaz-Pérez, Rodolfo Hernández-Gutiérrez, Horacio Bach iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0299520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jorge Hernández-Bello und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud Universidad de Guadalajara, Guadalajara, Mexico. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Guadalajara, Antibody Engineering and Proteomics Facility, Immunity and Infection Research Centre, Vancouver, BC, Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the COVID-19 pandemic, the Ad5-nCoV vaccine was applied to the Mexican population before the WHO approved it. In a transversal study, we compare the CanSino vaccine efficacy and a natural SARS-CoV-2 infection in eliciting neutralizing antibodies against the SARS-CoV-2 Delta variant in Guadalajara, Mexico. Participants between 30–60 years were included in the study and classified into three groups: 1) Natural immunity (unvaccinated), 2) Vaccine-induced immunity (vaccinated individuals without a COVID-19 history), and 3) Natural immunity + vaccine-induced immunity. These groups were matched by age and gender. We assessed the ability of individuals’ serum to neutralize the Delta variant and compared the results of the different groups using a neutralization test followed by plaque-forming units. Results showed that 39% of individuals’ serum with a history of COVID-19 (natural immunity, Group 1) could not neutralize the Delta variant, compared to 33% in vaccinated individuals without COVID-19 (vaccine immunity, Group 2). In contrast, only 7% of vaccinated individuals with a history of COVID-19 (natural + vaccine immunities) could not neutralize the Delta variant. We concluded that the effectiveness of the Ad5-nCoV vaccine to induce neutralizing antibodies against the Delta variant is comparable to that of natural infection (61% vs . 67%). However, in individuals with both forms of immunity (Group 3), it increased to 93%. Based on these results, despite the Ad5-nCoV vaccine originally being designed as a single-dose regimen, it could be recommended that even those who have recovered from COVID-19 should consider vaccination to boost their immunity against this variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansAntibodies, NeutralizingMexicoPandemicsCOVID-19 VaccinesVaccinationAntibodies, Viral

Substanzen

Ad5-nCoV vaccineAntibodies, NeutralizingCOVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud Universidad de Guadalajara, Guadalajara, Mexico.
  • Division of Infectious Diseases, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
  • Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Jalisco, Mexico.

ORCID-Profile: José F Muñoz-Valle, Horacio Bach

Förderung

  • University of Guadalajara
  • Antibody Engineering and Proteomics Facility, Immunity and Infection Research Centre, Vancouver, BC, Canada

Zitieren

APA

Hernández-Bello, J., Lorenzo-Leal, A. C., Muñoz-Valle, J. F., Morales-Núñez, J. J., Díaz-Pérez, S. A., Hernández-Gutiérrez, R., & Bach, H. (2024). Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population. PLOS ONE. https://doi.org/10.1371/journal.pone.0299520

Vancouver

Hernández-Bello J, Lorenzo-Leal AC, Muñoz-Valle JF, Morales-Núñez JJ, Díaz-Pérez SA, Hernández-Gutiérrez R, et al. Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population. PLOS ONE. 2024. doi:10.1371/journal.pone.0299520

BibTeX
@article{HernndezBello2024,
  author = {Hernández-Bello, Jorge and Lorenzo-Leal, Ana C and Muñoz-Valle, José F and Morales-Núñez, José J and Díaz-Pérez, Saul A and Hernández-Gutiérrez, Rodolfo and Bach, Horacio},
  title = {Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0299520}
}
Kostenlos starten →